Literature DB >> 10382187

The Index of Nausea, Vomiting, and Retching: a new format of the lndex of Nausea and Vomiting.

V A Rhodes1, R W McDaniel.   

Abstract

PURPOSE/
OBJECTIVES: To determine the reliability of the Index of Nausea, Vomiting, and Retching (INVR), a new format of the Rhodes Index of Nausea and Vomiting Form 2 (INV-2). DESIGN AND
SETTING: A parallel form study was conducted at a large, Midwestern teaching hospital and a cancer center. SAMPLE: Convenience sample of 159 subjects: 40 obstetrical, 60 oncological, 59 medical/surgical.
METHODS: Two instruments, the INVR and the INV-2, were administered approximately 30-60 minutes apart. One-half of the subjects completed the INVR first, and the other half completed the INV-2 first. MAIN OUTCOME MEASURES: Equivalency measures of reliability correlation coefficients for both instruments.
FINDINGS: A high rate of agreement was found in the responses between the two forms. In cases of clear disagreement, the responses to the INVR were more frequently consistent than the responses to the original form.
CONCLUSIONS: INVR has tested reliability and is more user friendly for the patient and the healthcare provider. IMPLICATIONS FOR NURSING PRACTICE: Nurses have a focal role in managing symptoms. Managing nausea, vomiting, and retching requires excellent assessment skills of the patient's personal symptom experience and knowledge of pharmacology. Efficient, cost-saving assessments require accurate self-report instruments that permit patients to quantify their symptom experiences. The INVR can provide a scientific base from which to prescribe and teach patients and may improve their quality of life. Reliable and valid self-reporting instruments are essential for managing these adverse symptoms.

Entities:  

Mesh:

Year:  1999        PMID: 10382187

Source DB:  PubMed          Journal:  Oncol Nurs Forum        ISSN: 0190-535X            Impact factor:   2.172


  40 in total

Review 1.  A review of patient self-report tools for chemotherapy-induced nausea and vomiting.

Authors:  Sarah G Brearley; Caroline V Clements; Alex Molassiotis
Journal:  Support Care Cancer       Date:  2008-06-13       Impact factor: 3.603

2.  Evaluation of the validity of chemotherapy-induced nausea and vomiting assessment in outpatients using the Japanese version of the MASCC antiemesis tool.

Authors:  Yuka Matsuda; Kenji Okita; Tomohisa Furuhata; Goro Kutomi; Kentaro Yamashita; Yasushi Sato; Rishu Takimoto; Koichi Hirata
Journal:  Support Care Cancer       Date:  2015-05-24       Impact factor: 3.603

Review 3.  Treatment options for hyperemesis gravidarum.

Authors:  Amy Abramowitz; Emily S Miller; Katherine L Wisner
Journal:  Arch Womens Ment Health       Date:  2017-01-09       Impact factor: 3.633

4.  Validation of simplified postoperative nausea and vomiting intensity scale in Taiwan.

Authors:  Hsun-Chang Shin; Ting-Wei Kang; Yu Hua Wu; H Sunny Sun; Chia-Chih Alex Tseng
Journal:  J Clin Monit Comput       Date:  2017-12-01       Impact factor: 2.502

Review 5.  The psychometric properties of cancer multisymptom assessment instruments: a clinical review.

Authors:  Aynur Aktas; Declan Walsh; Jordanka Kirkova
Journal:  Support Care Cancer       Date:  2015-04-19       Impact factor: 3.603

6.  Efficacy of palonosetron and ramosetron on postoperative nausea and vomiting related to intravenous patient-controlled analgesia with opioids after gynecological laparoscopic surgery (double-blinded prospective randomized controlled trial).

Authors:  Seong-Hyop Kim; Chung-Sik Oh; Sun Joo Lee
Journal:  J Anesth       Date:  2015-03-04       Impact factor: 2.078

7.  The effect of oral and IV ramosetron on postoperative nausea and vomiting in patients undergoing gynecological laparoscopy with total intravenous anesthesia.

Authors:  Dongchul Lee; Ji Young Kim; Jin Woo Shin; Chun Hoe Ku; Yeon Soo Park; Hyun Jeong Kwak
Journal:  J Anesth       Date:  2009-02-22       Impact factor: 2.078

8.  Population pharmacokinetics and prophylactic anti-emetic efficacy of ramosetron in surgical patients.

Authors:  Yong-Hun Lee; Jae-Hyeon Seo; Kyung-Tae Min; Young-Jin Lim; Seong-Wook Jeong; Eun-Kyung Lee; Byung-Moon Choi; Gyu-Jeong Noh
Journal:  Br J Clin Pharmacol       Date:  2016-06-08       Impact factor: 4.335

9.  Endocannabinoid-related lipids are increased during an episode of cyclic vomiting syndrome.

Authors:  T Venkatesan; Y Zadvornova; H Raff; C J Hillard
Journal:  Neurogastroenterol Motil       Date:  2016-04-20       Impact factor: 3.598

10.  Hyperdopaminergic crises in familial dysautonomia: a randomized trial of carbidopa.

Authors:  Lucy Norcliffe-Kaufmann; Jose Martinez; Felicia Axelrod; Horacio Kaufmann
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.